What Are The Risk Factors For Genpact Limited (G)?

As of Friday close, Genpact Limited’s (NYSE:G) stock was up $0.71, moving up 1.68 percent to $43.06. The average number of shares traded per day over the past five days has been 2,328,920 shares. 5 times new highs have been achieved over the past 5 days, with a $2.52 gain in that time frame. In the last twenty days, the average volume was 1,478,480, while in the previous 50 days, it was 1,116,358.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


Since last month, G stock rose 0.14%. Shares of the company fell to $37.68 on 05/05/22, the lowest level in the past month. A 52-week high of $54.03 was reached on 01/04/22 after having rallying from a 52-week low of $37.68. Since the beginning of this year, G’s stock price has dropped by -18.88% or -$10.02, and marked a new high 2 times. However, the stock has declined by -20.30% since its 52-week high.

Genpact Limited (G) last reported insider trading activity 123 days ago on Jan 11. White Heather, the SVP & Chief Legal Officer of the company, disposed of 15,204 shares for $52.15 on Jan 11. It resulted in a $792,951 divestment by the insider. Kalra Balkrishan sold 5,000 shares at an average price of $50.73 on Dec 13. The insider now owns 177,268 shares following the transaction. On Sep 15, Senior Vice President Kalra Balkrishan sold 5,000 shares at $50.18 apiece. The transaction was valued at $250,910.

Valuation Metrics

Right now, Genpact Limited (G) has a P/E ratio of about 22.49. The stock’s beta is 1.41. Besides these, the trailing price-to-sales (P/S) ratio of 1.88, the price-to-book (PB) ratio of 4.25, and the price-to-cash flow ratio of 15.93 may also be considered.

The latest dividend of $0.1250 per share was paid out, which is 15.74% more than last year’s $0.1080. On Friday February 11 2022, a $0.0170 dividend increase was announced.

Financial Health

In the three months ended March 30, Genpact Limited’s quick ratio stood at 1.50, while its current ratio was 1.50, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending March 30 was 0.68, and the total debt-to-equity ratio was 0.89. On the profitability front, the trailing twelve-month gross margin is 35.60% percent. In the year ended March 30, operating margins totaled 12.70%. Based on annual data, G earned $1.43 billion in gross profit and brought in $4.02 billion in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 11.00%. Return on equity (ROE) for the past 12 months was 20.00%.

In Genpact Limited’s quarter-end financial report for March 30, it reported total debt of $1.26 billion. According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. G’s revenue rose 11.45% to $1.07 billion during the quarter, while net income inched up to $1.07 billion. While analysts expected Genpact Limited to report $0.5 quarterly earnings, the actual figure was $0.57 per share, beating the consensus estimate by 14.00%. During the quarter, the company generated $170.72 million in EBITDA. The liabilities of Genpact Limited were 3.12 billion at the end of its most recent quarter ended March 30, and its total debt was $2.02 billion. The value of shareholders’ equity is $185.15 million.

Technical Picture

This quick technical analysis looks at Genpact Limited’s (G) price momentum. With a historical volatility rate of 44.70%, the RSI 9-day stood at 63.13% on 13 May.

With respect to its five-day moving average, the current Genpact Limited price is up by +6.22% percent or $2.52. At present, G shares trade +2.23% above its 20-day simple moving average and -14.10% percent below its 100-day simple moving average. However, the stock is currently trading approximately +1.03% above its SMA50 and -13.55% below its SMA200.

Stochastic coefficient K was 90.18% and Stochastic coefficient D was 75.10%, while ATR was 1.39. Given the Stochastic reading of 93.57% for the 14-day period, the RSI (14) reading has been calculated as 57.23%. As of today, the MACD Oscillator reading stands at 1.48, while the 14-day reading stands at 1.59.

Analyst Ratings

Genpact Limited downgraded its rating on Genpact Limited (NYSE: G) to a Market perform in a note to investors on February 14, 2022. The analysts firm previously had an Outperform rating on the stock.Genpact Limited (G) has been rated Overweight by analysts. According to 0 brokerage firms, G is a sell, and 5 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 1 analyst rate Genpact Limited stock as buy, with 6 recommending it as overweight.

With a median target price of $52.00, the current consensus forecast for the stock is $45.00 – $58.00. Based on these forecasts, analysts predict Genpact Limited (G) will achieve an average price target of $51.60.


Please enter your comment!
Please enter your name here

Hot Topics

Related Articles